Market Closed -
NSE India S.E.
12:43:47 03/05/2024 BST
|
5-day change
|
1st Jan Change
|
3,951
INR
|
-0.35%
|
|
-1.63%
|
+1.21%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
452,120
|
528,030
|
961,740
|
1,168,606
|
749,511
|
1,048,853
|
-
|
-
|
Enterprise Value (EV)
1 |
438,040
|
527,140
|
940,228
|
1,140,454
|
707,412
|
1,002,820
|
1,000,527
|
995,427
|
P/E ratio
|
33.4
x
|
38.4
x
|
48.5
x
|
39.5
x
|
41.1
x
|
67.8
x
|
51.3
x
|
41.4
x
|
Yield
|
0.94%
|
0.8%
|
0.55%
|
0.68%
|
1.06%
|
0.67%
|
0.73%
|
0.82%
|
Capitalization / Revenue
|
9.14
x
|
9.79
x
|
13.8
x
|
13
x
|
9.65
x
|
13.7
x
|
11.8
x
|
10.2
x
|
EV / Revenue
|
8.86
x
|
9.77
x
|
13.5
x
|
12.7
x
|
9.11
x
|
13.1
x
|
11.3
x
|
9.7
x
|
EV / EBITDA
|
23.4
x
|
28.9
x
|
32.9
x
|
29.4
x
|
29.9
x
|
47.5
x
|
35.7
x
|
28.6
x
|
EV / FCF
|
198
x
|
1,611
x
|
90.7
x
|
95.1
x
|
35.6
x
|
110
x
|
123
x
|
78
x
|
FCF Yield
|
0.51%
|
0.06%
|
1.1%
|
1.05%
|
2.81%
|
0.91%
|
0.81%
|
1.28%
|
Price to Book
|
6.5
x
|
7.22
x
|
10.4
x
|
9.96
x
|
5.87
x
|
7.83
x
|
7.16
x
|
6.43
x
|
Nbr of stocks (in thousands)
|
265,469
|
265,469
|
265,469
|
265,469
|
265,469
|
265,469
|
-
|
-
|
Reference price
2 |
1,703
|
1,989
|
3,623
|
4,402
|
2,823
|
3,951
|
3,951
|
3,951
|
Announcement Date
|
25/05/19
|
06/06/20
|
29/05/21
|
23/05/22
|
20/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
49,463
|
53,944
|
69,694
|
89,598
|
77,675
|
76,829
|
88,647
|
102,571
|
EBITDA
1 |
18,718
|
18,222
|
28,599
|
38,819
|
23,678
|
21,098
|
28,031
|
34,765
|
EBIT
1 |
17,029
|
16,359
|
26,044
|
35,704
|
20,246
|
17,652
|
24,184
|
30,558
|
Operating Margin
|
34.43%
|
30.33%
|
37.37%
|
39.85%
|
26.07%
|
22.98%
|
27.28%
|
29.79%
|
Earnings before Tax (EBT)
1 |
18,551
|
18,195
|
26,660
|
36,835
|
23,686
|
20,664
|
27,480
|
34,020
|
Net income
1 |
13,527
|
13,765
|
19,843
|
29,604
|
18,234
|
15,405
|
20,398
|
25,221
|
Net margin
|
27.35%
|
25.52%
|
28.47%
|
33.04%
|
23.47%
|
20.05%
|
23.01%
|
24.59%
|
EPS
2 |
50.96
|
51.85
|
74.75
|
111.5
|
68.69
|
58.25
|
76.95
|
95.38
|
Free Cash Flow
1 |
2,212
|
327.3
|
10,367
|
11,986
|
19,867
|
9,118
|
8,136
|
12,767
|
FCF margin
|
4.47%
|
0.61%
|
14.88%
|
13.38%
|
25.58%
|
11.87%
|
9.18%
|
12.45%
|
FCF Conversion (EBITDA)
|
11.82%
|
1.8%
|
36.25%
|
30.88%
|
83.9%
|
43.22%
|
29.02%
|
36.72%
|
FCF Conversion (Net income)
|
16.35%
|
2.38%
|
52.25%
|
40.49%
|
108.96%
|
59.19%
|
39.89%
|
50.62%
|
Dividend per Share
2 |
16.00
|
16.00
|
20.00
|
30.00
|
30.00
|
26.35
|
28.98
|
32.30
|
Announcement Date
|
25/05/19
|
06/06/20
|
29/05/21
|
23/05/22
|
20/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
17,014
|
17,882
|
19,606
|
19,875
|
24,932
|
25,184
|
22,545
|
18,545
|
17,077
|
19,508
|
17,780
|
19,312
|
19,926
|
20,742
|
20,927
|
EBITDA
1 |
6,912
|
7,163
|
8,520
|
8,181
|
10,972
|
11,044
|
8,467
|
6,210
|
4,083
|
4,876
|
5,040
|
5,837
|
5,649
|
6,011
|
-
|
EBIT
1 |
6,230
|
6,462
|
7,788
|
7,407
|
10,173
|
10,234
|
7,630
|
5,353
|
3,215
|
4,006
|
4,110
|
4,948
|
4,786
|
4,674
|
5,169
|
Operating Margin
|
36.62%
|
36.14%
|
39.72%
|
37.27%
|
40.8%
|
40.64%
|
33.84%
|
28.86%
|
18.83%
|
20.53%
|
23.12%
|
25.62%
|
24.02%
|
22.53%
|
24.7%
|
Earnings before Tax (EBT)
1 |
6,421
|
-
|
8,145
|
7,596
|
10,337
|
10,757
|
8,513
|
6,152
|
4,356
|
4,665
|
4,920
|
5,611
|
5,351
|
5,827
|
-
|
Net income
1 |
4,706
|
5,020
|
5,571
|
6,065
|
9,029
|
8,946
|
7,020
|
4,936
|
3,068
|
3,210
|
3,560
|
4,264
|
4,134
|
4,442
|
-
|
Net margin
|
27.66%
|
28.07%
|
28.41%
|
30.51%
|
36.21%
|
35.52%
|
31.14%
|
26.62%
|
17.97%
|
16.45%
|
20.02%
|
22.08%
|
20.75%
|
21.42%
|
-
|
EPS
2 |
17.73
|
18.91
|
20.99
|
22.84
|
33.99
|
33.70
|
26.44
|
18.60
|
11.56
|
12.09
|
13.41
|
15.34
|
15.73
|
15.94
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
06/02/21
|
29/05/21
|
07/08/21
|
06/11/21
|
11/02/22
|
23/05/22
|
12/08/22
|
07/11/22
|
03/02/23
|
20/05/23
|
14/08/23
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
14,080
|
890
|
21,512
|
28,152
|
42,098
|
46,034
|
48,326
|
53,427
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
2,212
|
327
|
10,367
|
11,986
|
19,867
|
9,118
|
8,136
|
12,767
|
ROE (net income / shareholders' equity)
|
21%
|
19.3%
|
21%
|
28.2%
|
14.9%
|
11.8%
|
14.3%
|
16.2%
|
ROA (Net income/ Total Assets)
|
18.3%
|
-
|
20.6%
|
24.5%
|
13.1%
|
9.65%
|
13%
|
15%
|
Assets
1 |
74,120
|
-
|
96,550
|
120,744
|
139,067
|
159,636
|
156,907
|
168,143
|
Book Value Per Share
2 |
262.0
|
275.0
|
349.0
|
442.0
|
481.0
|
505.0
|
552.0
|
614.0
|
Cash Flow per Share
2 |
35.90
|
45.80
|
73.30
|
72.00
|
92.70
|
65.50
|
75.40
|
92.90
|
Capex
1 |
7,331
|
11,832
|
9,102
|
7,132
|
4,730
|
10,200
|
9,649
|
9,086
|
Capex / Sales
|
14.82%
|
21.93%
|
13.06%
|
7.96%
|
6.09%
|
13.28%
|
10.89%
|
8.86%
|
Announcement Date
|
25/05/19
|
06/06/20
|
29/05/21
|
23/05/22
|
20/05/23
|
-
|
-
|
-
|
Last Close Price
3,951
INR Average target price
3,442
INR Spread / Average Target -12.87% Consensus |
1st Jan change
|
Capi.
|
---|
| +1.21% | 12.58B | | +21.85% | 546B | | -4.77% | 359B | | +16.97% | 323B | | +5.69% | 290B | | +13.68% | 234B | | +3.65% | 198B | | -11.12% | 194B | | +8.08% | 167B | | -3.40% | 157B |
Other Pharmaceuticals
|